Penserra Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-24,342
| Closed | -$1.86M | – | 1474 |
|
|
2022
Q1 | $1.86M | Buy |
+24,342
| New | +$1.86M | 0.04% | 348 |
|
|
2021
Q4 | – | Sell |
-1,020
| Closed | -$57K | – | 1497 |
|
|
2021
Q3 | $57K | Buy |
1,020
+20
| +2% | +$1.12K | ﹤0.01% | 1019 |
|
|
2021
Q2 | $60K | Buy |
1,000
+20
| +2% | +$1.2K | ﹤0.01% | 951 |
|
|
2021
Q1 | $68K | Sell |
980
-15
| -2% | -$1.04K | ﹤0.01% | 766 |
|
|
2020
Q4 | $59K | Buy |
995
+629
| +172% | +$37.3K | ﹤0.01% | 671 |
|
|
2020
Q3 | $22K | Buy |
+366
| New | +$22K | ﹤0.01% | 728 |
|